🇺🇸 Vitamin D (Cholecalciferol ) in United States

135 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 135

Most-reported reactions

1. Disease Progression — 21 reports (15.56%)
2. Death — 19 reports (14.07%)
3. Fatigue — 18 reports (13.33%)
4. Diarrhoea — 16 reports (11.85%)
5. Pyrexia — 12 reports (8.89%)
6. Nausea — 11 reports (8.15%)
7. Dizziness — 10 reports (7.41%)
8. Dyspnoea — 10 reports (7.41%)
9. Back Pain — 9 reports (6.67%)
10. Drug Ineffective — 9 reports (6.67%)

Source database →

Frequently asked questions

Is Vitamin D (Cholecalciferol ) approved in United States?

Vitamin D (Cholecalciferol ) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Vitamin D (Cholecalciferol ) in United States?

McGill University Health Centre/Research Institute of the McGill University Health Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.